The phrase "a rationale for examining" is correct and usable in written English.
It can be used when discussing the reasoning or justification behind investigating a particular subject or issue.
Example: "The study provides a rationale for examining the effects of climate change on local ecosystems."
Alternatives: "a justification for exploring" or "a reason for investigating".
First, a rationale for examining stability as a distinct friendship dimension is presented.
The results of this study provide a rationale for examining the use of IDR-peptides as potential therapeutic candidates for chronic inflammatory diseases such as inflammatory arthritis.
2) An increase in blebbing in the invading cells is mentioned throughout in the manuscript, and is used as a rationale for examining mDia1.
Older populations have disproportionately more avoidable hospitalizations than younger cohorts [ 22, 27], providing a rationale for examining trends among older adults, although AHRs were originally developed to describe hospitalizations among the population aged 0 64.
Nevertheless, our data showing that miR132 markedly affects MeCP2 expression in vivo, provide a strong rationale for examining whether dysregulation of miR132 could be contributing to Rett Syndrome and other MeCP2-related disorders.
In human patients, OL apoptosis is observed as early as 3 h after SCI and persists for weeks, providing a strong rationale for examining the mechanisms leading to OL death in the injured spinal cord.
Secondly, significant differences in the physiologically relevant, in-planta induced ROS in these two accessions provided a compelling rationale for examining the differences in gene expression at this time point.
This study provides a rationale for further examining the use of IDR peptides as potential therapeutics for the management of inflammatory arthritis and possibly other diseases characterized by chronic inflammation.
Early observations that HDACi could not only induce cell cycle arrest and apoptosis in cancer cell lines, but also block inflammatory cytokine production in these cells, provided a rationale for experiments examining whether HDACi could be used therapeutically to treat immune-mediated inflammatory diseases.
The rationale for examining a two-factor, second-order structure considering generic HRQOL as one factor and disease-specific HRQOL as another factor is supported by the literature in which generic HRQOL and disease-specific HRQOL are considered to be distinct, yet complementary concepts [ 54].
Data from studies that administered a chelator to animals with experimental autoimmune encephalomyelitis, a model of MS, support the rationale for examining this treatment approach in MS. Preliminary clinical studies have been performed in MS patients using deferoxamine.
